D305-0415 Screening compound: N-{2-[(4-benzylpiperazin-1-yl)methyl]-1-ethyl-1H-1,3-benzodiazol-5-yl}-2-phenoxyacetamide

D305-0415 Screening compound: N-{2-[(4-benzylpiperazin-1-yl)methyl]-1-ethyl-1H-1,3-benzodiazol-5-yl}-2-phenoxyacetamide
D305-0415 Screening compound: N-{2-[(4-benzylpiperazin-1-yl)methyl]-1-ethyl-1H-1,3-benzodiazol-5-yl}-2-phenoxyacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D305-0415
N-{2-[(4-benzylpiperazin-1-yl)methyl]-1-ethyl-1H-1,3-benzodiazol-5-yl}-2-phenoxyacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D305-0415

Molecular Formula

C29H33N5O2 (C29 H33 N5 O2)

Compound Name

N-{2-[(4-benzylpiperazin-1-yl)methyl]-1-ethyl-1H-1,3-benzodiazol-5-yl}-2-phenoxyacetamide

IUPAC name

N-{2-[(4-benzylpiperazin-1-yl)methyl]-1-ethyl-1H-13-benzodiazol-5-yl}-2-phenoxyacetamide

SMILES

CCn1c(ccc(NC(COc2ccccc2)=O)c2)c2nc1CN1CCN(Cc2ccccc2)CC1

InChI

InChI=1S/C29H33N5O2/c1-2-34-27-14-13-24(30-29(35)22-36-25-11-7-4-8-12-25)19-26(27)31-28(34)21-33-17-15-32(16-18-33)20-23-9-5-3-6-10-23/h3-14,19H,2,15-18,20-22H2,1H3,(H,30,35)

InChI Key

XVGBGNZEVHOJGT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD09767189

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

483.61

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.254

Distribution Coefficient, logD

3.985

Water Solubility, LogSw

-4.06

Polar Surface Area

48.790

Acid Dissociation Constant (pKa)

12.44

Base Dissociation Constant (pKb)

7.33

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.00

D305-0415 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

PI3K-Targeted Library (17255 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with D305-0415 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D305-0415?
Check Price and Availability of D305-0415, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D305-0415 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D305-0415
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D305-0415
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D305-0415 available by request